UBS raises Covid-19 loss estimate to $30bn-$60bn on non-US BI fears
Analysts at UBS have raised their estimate of insured losses from the coronavirus pandemic to between $30bn and $60bn, from their previous range of $20bn to $40bn.
If you are a subscriber, please sign back in to read this article
If you are not currently a subscriber please see contact details below